Research Article

Mitophagy Impairment Aggravates Cisplatin-Induced Ototoxicity

Figure 1

Cisplatin reduces the HEI-OC1 cell viability and upregulates mitophagy-associated proteins. HEI-OC1 cells were treated with 10 μM cisplatin for 0 (control), 8, 16, and 24 h. (a) Cell survival decreasing with cisplatin exposure in a time-dependent manner. (b, c) Cisplatin exposure increasing the expression of mitophagy-associated proteins. (b) Representative immunoblots of PINK1, Parkin, BNIP3, FUNDC1, p62, LC3B, and COX IV (loading control) from cell lysates harvested after the indicated cisplatin treatment time. (c) Mean changes in the expression of PINK1, Parkin, BNIP3, FUNDC1, p62, and LC3B relative to that of COX IV using densitometry analyses. Data are presented as the of five independent experiments. ; .
(a)
(b)
(c)